Free tool
FAERS Monitor: Ceftriaxone and Dextrose In Duplex Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 050796 or its brand name (Ceftriaxone and Dextrose In Duplex Container, Ceftriaxone Sodium). Reports on generic versions are filed under their own applications.
Reports
33,350
Serious
31,411
94% of reports
Hospitalization
18,217
Death reported
5,724
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use3,609
- drug ineffective3,316
- pyrexia1,775
- acute kidney injury1,662
- condition aggravated1,427
- dyspnoea1,143
- pneumonia1,101
- drug interaction1,057
- vomiting1,039
- nausea996
- drug reaction with eosinophilia and systemic symptoms940
- diarrhoea921
- hypotension901
- sepsis879
- rash876
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 136 |
| 2005 | 226 |
| 2006 | 237 |
| 2007 | 252 |
| 2008 | 360 |
| 2009 | 411 |
| 2010 | 375 |
| 2011 | 507 |
| 2012 | 698 |
| 2013 | 790 |
| 2014 | 1,024 |
| 2015 | 969 |
| 2016 | 1,254 |
| 2017 | 1,422 |
| 2018 | 2,080 |
| 2019 | 2,192 |
| 2020 | 3,821 |
| 2021 | 3,621 |
| 2022 | 2,871 |
| 2023 | 2,637 |
| 2024 | 2,813 |
| 2025 | 2,709 |
| 2026 | 1,944 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,020,809 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug reaction with eosinophilia and systemic symptomsSignal | 940 | 23.9 | 22.4 | 19,852 |
| acute kidney injurySignal | 1,662 | 6.9 | 6.6 | 8,370 |
| sepsisSignal | 879 | 5.0 | 4.7 | 2,803 |
| drug interactionSignal | 1,057 | 4.2 | 4.0 | 2,600 |
| pyrexiaSignal | 1,775 | 3.2 | 3.1 | 2,789 |
| condition aggravatedSignal | 1,427 | 3.0 | 2.8 | 1,880 |
| hypotensionSignal | 901 | 2.8 | 2.7 | 1,079 |
| off label useSignal | 3,609 | 2.6 | 2.5 | 3,710 |
| pneumoniaSignal | 1,101 | 2.1 | 2.0 | 683 |
| drug ineffective | 3,316 | 1.6 | 1.5 | 768 |
| vomiting | 1,039 | 1.4 | 1.3 | 118 |
| dyspnoea | 1,143 | 1.3 | 1.2 | 69 |
| rash | 876 | 1.3 | 1.2 | 50 |
| diarrhoea | 921 | 0.9 | 0.8 | 11 |
| nausea | 996 | 0.8 | 0.7 | 55 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.